Search

Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan Kettering Cancer Center shows that circulating tumor cells - cancer cells that break away from a primary tumor and disseminate to other areas of the body - can also return to and grow in their tumor of origin, a newly discovered process called "self-seeding."

… Thursday, December 24, 2009 Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs. A new study by researchers at Memorial Sloan Kettering Cancer Center shows that

… Friday, November 8, 2024 Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first three quarters of 2024:   MSK’s financial performance through the third quarter of 2024 demonstrate positive and consistent financial results, with an excess

New data from researchers at MSK featured in the 2022 ASCO Annual Meeting press program and simultaneously published in The New England Journal of Medicine highlights a novel antibody-drug conjugate that doubled progression-free survival in HER2-low metastatic breast cancer.

… Sunday, June 5, 2022 Update: On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low  breast cancer  that has spread to other parts of the body and is unable to be surgically removed. The drug,  https://www.mskcc.org/cancer-care/patient-education/fam-trastuzumab-deruxtecan

Seven students will be awarded PhD degrees on May 19, 2021, from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), an innovative doctoral program that prepares the next generation of basic laboratory scientists to work in research areas related to human disease with a focus on cancer.

… Monday, May 17, 2021 Seven students will be awarded PhD degrees on May 19, 2021, from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) , an innovative doctoral program that prepares the next generation of basic laboratory scientists to work in research areas related to human

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Tuesday, April 30, 2024 Victoria Blinder Awarded Funding from the Patient-Centered Outcomes Research Institute Victoria Blinder, MD, FASCO Victoria Blinder, MD, FASCO , medical oncologist, was  awarded funding from the Patient-Centered Outcomes Research Institute (PCORI) on behalf of the Alliance NCTN

Read an interview with Sloan Kettering Institute Computational and Systems Biology Chair Dana Pe'er.

… Friday, January 1, 2021 Dana Pe’er is Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute (SKI). She came to Memorial Sloan Kettering Cancer Center in 2016, with the goal of bringing her mathematical and computational expertise to bear on the problem of cancer. An

Get to know Ana Silveira, a computational biology postdoctoral fellow in the Sloan Kettering Institute.

… Thursday, March 26, 2020 Summary As part of Women’s History Month, we are profiling some of MSK’s star female graduate students and postdoctoral fellows training to be leaders in their fields. Ana Silveira is a postdoctoral fellow in the Chodera lab  in the Sloan Kettering Institute. When you look back

The U.S. Food and Drug Administration (FDA) qualified MSK’s WOUND-Q™ questionnaire as a Medical Device Development Tool (MDDT) in November 2024.

… Thursday, January 23, 2025 The U.S. Food and Drug Administration (FDA) qualified MSK’s WOUND-Q™ questionnaire as a Medical Device Development Tool (MDDT) in November 2024. WOUND-Q is the latest of only 18 MDDTs that have earned the qualification since the MDDT program began in 2017. WOUND-Q contains

Cassidy Cobbs is many things: a valued colleague who works at the Sloan Kettering Institute; a doting parent to a pit bull named Mando; a beloved sibling; and a passionate baseball fan, who memorized the stats of former player, Ryne Sandberg, at the age of 5. What Cassidy is not is someone who identifies as either a man or a woman.

… Friday, March 31, 2023 Cassidy Cobbs is many things — A valued colleague and employee who works at the Sloan Kettering Institute  — the basic and translational research arm of Memorial Sloan Kettering Cancer Center (MSK). A doting parent to a pit bull named Mando. A beloved sibling. And a passionate

Reducing the radiation therapy dose currently used to treat high-risk neuroblastoma in children is possible, according to the promising results from our recent prospective trial.

… Monday, May 13, 2019 Reducing the radiation therapy dose currently used to treat high-risk neuroblastoma in children is possible, according to the promising results from our recent prospective trial, meaning reduced toxicities for many of these young patients. Our study, published in the International